What is Emtricitabine-Tenofovir?

Category: Prescription Drugs

Most popular types: Truvada Truvada HIV Pre-Exposure Prophylaxis Ricovir-EM Show all

false

Emtricitabine and tenofovir is an antiviral medication that prevents human immunodeficiency virus (HIV) from reproducing in your body. Emtricitabine and tenofovir treats HIV, which causes acquired immunodeficiency syndrome (AIDS).

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Human immunodeficiency virus (HIV) 329 133
Support immune health 11 3
Increase effect of another treatment 4 2
Prevent infection 3 1
Acquired immune deficiency syndrome 2 0
General health 2 0

Show all 9 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 8
Moderate 22
Mild 34
None 75

Commonly reported side effects and conditions associated with Emtricitabine-Tenofovir

Side effect Patients
Diarrhea 13
Loss of energy 6
Headaches 5
Dizziness 4
Fatigue 4
Nausea 4

Show all 44 reported side effects

Dosages

Based on patients currently taking Emtricitabine-Tenofovir

Dosage Patients
200 mg-300 mg daily 10
200-300 mg daily 7
300 mg daily 1

Why patients stopped taking Emtricitabine-Tenofovir

Multiple reasons could be selected

Reason Patients
Doctor's advice 41
Other 27
Side effects too severe 13
Course of treatment ended 10
Did not seem to work 4
Expense 4
Change in health plan coverage 3
Personal research 1
See all 85 patients who've stopped taking Emtricitabine-Tenofovir

Duration

Currently taking Emtricitabine-Tenofovir

Duration Patients
6 months - 1 year 2
1 - 2 years 2
2 - 5 years 8
5 - 10 years 3
10 years or more 3

Stopped taking Emtricitabine-Tenofovir

Duration Patients
Less than 1 month 4
1 - 6 months 23
6 months - 1 year 12
1 - 2 years 11
2 - 5 years 17
5 - 10 years 19
10 years or more 1
Adherence
Adherence Evaluations
Always 119
Usually 14
Sometimes 3
Never taken as prescribed 3
Burden
Burden Evaluations
Very hard to take 3
Somewhat hard to take 12
A little hard to take 25
Not at all hard to take 99
Cost per month
Cost per month Evaluations
$200+ 8
$100-199 2
$50-99 7
$25-49 10
< $25 62
Not specified 50

What people switch to and from

Patients started taking Emtricitabine-Tenofovir after stopping:

Treatment Patients
Efavirenz-Emtricitabine-Tenofovir (Atripla) 2
Atazanavir-cobicistat 1
Cobicistat-elvitegravir-emtricitabine-tenofovir disoproxil (Stribild) 1
Efavirenz (Sustiva) 1
Rilpivirine-Tenofovir-Emtricitabine (Complera) 1

Show all 6 treatments patients report switching from

Patients stopped taking Emtricitabine-Tenofovir and switched to:

Treatment Patients
Emtricitabine-Tenofovir Alafenamide (Descovy) 7
Cobicistat-elvitegravir-emtricitabine-tenofovir disoproxil (Stribild) 4
Abacavir-lamivudine (Epzicom) 3
Triumeq 2
Atazanavir (Reyataz) 1

Show all 9 treatments patients report switching to

Last updated:

20 patient evaluations for Emtricitabine-Tenofovir

Jul 14, 2016 (Started Aug 29, 2013)

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    None
  • Adherence
    Never taken as prescribed
  • Burden
    Not at all hard to take
Dosage: 200 mg-300 mg Daily
Cost: < $25 monthly

  • 0 helpful marks

Sep 30, 2015 (Started Oct 01, 2010)

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 200 mg-300 mg Daily
Cost: < $25 monthly

Jun 25, 2011 (Started Oct 01, 2010)

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    Mild
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 200 mg-300 mg Daily
Cost: < $25 monthly

  • 0 helpful marks

Aug 18, 2014 (Started Aug 01, 2014)

  • Effectiveness
    Can't tell (for human immunodeficiency virus (HIV))
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 200 mg-300 mg Daily

  • 0 helpful marks
Last updated:
Showing 3 of 20 patient evaluations for Emtricitabine-Tenofovir